Introduction
Hypertension is a complex etiological disease affecting as many as 874 million adults globally with the prevalence increasing annually [1, 2] . Hypertension is a noted risk factor for stroke, cardiovascular disease, and chronic kidney disease (CKD), the latter of which can progress to end-stage renal disease (ESRD), with higher incidence rates in individuals who are overweight, diabetic, aged intake high amounts of salt or have altered sleep patterns [3] [4] [5] . One of the primary drivers of increased blood pressure is angiotensin-II (Ang-II), a hormone that is activated, in part, by kidney-produced renin and subsequently travels throughout the body and adversely affecting multiple organ systems through increased inflammation and oxidative damage [6] [7] [8] . As hypertension is a multifactorial disease, so are the prescribed methods to combat its affects, including changes to diet, establishing an exercise regimen, renal denervation, as well as pharmaceutical intervention in the form of antihypertensive drug treatments [9] [10] [11] [12] [13] . While these treatment approaches can improve blood pressure, not all individuals are responsive, reinforcing the complexity of hypertension as well as highlighting the need to identify new mechanisms and pathways that can be utilized in regulating blood pressure.
Recent studies have highlighted the importance of gut microbiota on physiological processes, such as metabolism, and have been linked with several chronic diseases, including diabetes, obesity, CKD, cardiovascular disease and hypertension [14] [15] [16] [17] . Some of the byproducts of gut microbiota are metabolites known as short chain fatty acids (SCFAs), mainly acetic acid, propionic acid, and butyric acid, can diffuse into the bloodstream and affect multiple tissues and processes, including metabolism, energy balance and the immune system [18] [19] [20] [21] . Moreover, SCFAs have been implicated in blood pressure regulation through interaction with target receptors. Olfr78 is a SCFA receptor found in the kidney and has been shown to respond to SCFA stimulation by increasing blood pressure through increased renin release and subsequent vasoconstriction [22] . Conversely, Gpr41 SCFA receptor has been shown to have hypotensive effects as Gpr41 knockout mice have increased systolic blood pressure [23] . Evidence from human studies also support a role for the gut microbiome and SCFAs in blood pressure regulation by examining changes in microbiota to interventions such as probiotics [24] . While several associations exist between gut microbiota SCFAs and blood pressure, regulation of these receptors are not clearly defined.
The gaseous molecule, hydrogen sulfide (H 2 S) is involved in regulating several physiological processes, as well as having a role in blood pressure regulation [25] [26] [27] [28] . In the kidney, H 2 S has been shown to mitigate kidney damage due to aging, hyperhomocysteinemia-induced damage, and hyperglycemic-induced matrix remodeling and deposition [29] [30] [31] . Recently, H 2 S production in the colon by gut microbiota has been linked with blood pressure regulation as well as the bioavailability on the whole organism [26, 32] . Sulfate-reducing bacteria are present in the gut of humans, with one of the main species being Desulfovibrio piger, and is influenced by factors, such as diet [33] . However, the role and influence of H 2 S on the gut microbiome genera and on renal function, in particular SCFA receptors, remains to be elucidated.
In this study, we investigated the impact of exogenous administration of the H 2 S donor GYY 4137 on the gut microbiome composition as well as SCFA target receptors in the hypertensive kidney. MicroRNAs are small, highly conserved non-coding RNAs that regulate gene expression and have been implicated in several kidney diseases and hypertension [34] [35] [36] . In addition, SCFA receptors have been shown to play a role in blood pressure regulation in the kidney; however, the regulation of these receptors has not been evaluated.
Materials and methods

Animals
WT (C57BL/J) male mice were obtained from Jackson Laboratories (Bar Harbor, ME) and housed in the animal care facility on a 12 h light/ dark cycle at the University of Louisville and the study was approved by University of Louisville Institutional Animal Care and Use Committee. All mice were fed standard chow (LabDiet 5010, St. Louis, MO), with free access to food and water. Animals aged 10-12 weeks were grouped based on treatment, with an 'n' of 5 per group: WT, WT + GYY4137, WT + Ang-II, WT + GYY4137+Ang-II. Administration of Ang-II (Sigma, St. Louis, MO) was at a rate of 1000 ng/kg
weeks via Alzet mini osmotic pumps (Durect Corp., Cupertino, CA) and inserted subcutaneously on back right of mice. GYY4137 (Sigma, St. Louis, MO) treatments were given by intraperitoneally injection (133μM/kg
Cell culture and transfections and target prediction
Mouse Glomerular Endothelial Cells were maintained in Endothelial Cell Medium + 10% FBS and antibiotics from passage 12-16. Cells were transfected with mimics, or inhibitor, for miR-129-5p, miR-132-3p, and miR-329, as well as controls, obtained from Exiqon (Woburn, MA). Cells were seeded at 30% confluency in growth medium without antibiotics the day before transfections. A concentration of 50 nM for mimics, inhibitors, and controls were transfected using Lipofectamine RNAiMAX transfection reagent according to manufacturer's recommendations. Cells were transfected for a period of 48 h and subsequently collected in lysis buffer for Western blot analysis. TargetScan (http://www.targetscan.org/) and miRWalk 2.0 (http://zmf.umm.uniheidelberg.de/apps/zmf/mirwalk2/) were utilized to identify potential targets of microRNAs. Default settings were used interrogating the mouse database and lists were investigated for potential targets of interest.
RNA isolation
Total RNA was isolated from a portion of the kidney from all animals for each group and was used for downstream assays. Tissue was homogenized in QIAzol reagent using a BenchMark BeadBlaster (Edison, NJ) using 45 s pulses for six times and subsequently extracted and purified using the Qiagen miRNeasy Mini Kit (Valencia, CA) according to manufacturer's protocol. RNA concentration and quality was assessed using a NanoDrop Instrument (Thermo Scientific, Wilmington, DE)
DNA isolation and 16S sequencing
Microbial and host genomic DNA was isolated from fecal samples from mice at the end of the treatment period. DNA was extracted utilizing the ThermoFisher PureLink Microbiome DNA Purification Kit (ThermoFisher, Waltham, MA) and sent to the University of Louisville Genomics Core for library preparation and sequencing. Libraries were prepared using Illumina's 16S library preparation guide and the Nextera Index Kit (FC-121-1012). Sequencing was done using Illumina MiSeq Reagents Kit v3 (MS-102-3003, 600 cycles) on an Illumina MiSeq instrument. Sequencing data was analyzed by the University of Louisville Bioinformatics Core to determine species composition and diversity using Qiime 1.9.
Polymerase chain reaction
Genomic DNA (gDNA) was extracted from kidney tissue using the Qiagen DNeasy Blood and Tissue Kit (Valencia, CA) according to the manufacturer's recommendations. The quality and quantity was assessed using a Nanodrop 1000 spectrophotometer. PCR was performed on 100 ng of sample using GoTaq Hot Start Master Mix (Promega, Madison, WI) with primers designed through Primer3 software.
Table 1
Primers used for qPCR.
Gene
Forward Reverse
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Products were run out on a 1.0% agarose gel and visualized on a ChemiDoc XRS system (Bio-Rad, Hercules, CA). Primer sequences are listed in Table 1 .
Quantitative PCR
Quantitative PCR was carried out using the Bullseye EvaGreen qPCR MasterMix (MidSci, Valley Park, MO) on RNA samples extracted from tissue. 1 μg of total RNA was transcribed into cDNA using the Bio-Rad iScript Select cDNA Synthesis Kit (Bio-Rad, Hercules, CA) with primers designed against each gene using Primer3 software (Primer3). Subsequent qPCR reactions were setup and run on a Roche LightCycler 96 instrument (Roche, Indianapolis, IN) and run in triplicate using Gapdh as a reference. Table 1 contains primer sequences utilized.
Western blotting
Whole kidney tissues were homogenized with RIPA buffer (Boston BioProducts, Inc., Ashland, MA) containing protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) and phenylmethylsulfonyl fluoride. 100 μg of protein from each sample were loaded and electrophoresed in sodiumdodecyl sulphate-polyacrylamide gel electrophoresis, and transferred onto PVDF membranes. Membranes were probed with appropriate primary antibody at 4°C overnight. Olfr78 (Abcam, ab140907), Gpr41 (Sigma, SAB4501281), Gpr43 (Santa Cruz, sc293202), Tgfβ (Abcam, ab64715), Rorcγ (Abcam, ab207082), Il6 (Abcam, ab6672), Gpr120, (ThermoFisher, PA5-50973), Gapdh (Santa Cruz, sc32233). Respective Horseradish Peroxidase-conjugated secondary antibody incubation was for 2 h at room temperature. Membranes were developed using chemiluminescence (Pierce ECL Western blotting substrate; Thermo Scientific, Rockford, IL). Gapdh was used as loading control and band intensity was quantified using ImageJ software.
Immunofluorescence staining
Frozen kidney sections of 5 μm in thickness were fixed in ice cold acetone. Immunofluorescence staining was performed for Olfr78, Gpr41, Gpr43, Gpr120, Il-6, Tgfβ, Rorc with primary antibody incubation for overnight and subsequently incubated with appropriate secondary antibody and counterstained with DAPI. Images were captured by confocal microscope (FluoView1000; Olympus) and analyzed by Image ProPlus, version 7.0 (Media Cybernetics, Inc., Rockville, MD). 
ELISA
Plasma samples collected at the end of the treatment period were measured for the haptoglobin protein using an ELISA kit (Abcam ab157714, Cambridge, MA).
Glomerular filtration rate measurement
GFR measurements were taken based on previous studies [37, 38] with slight modifications. Mice were anesthetized with inhaled isoflurane and Nair ™ was applied to a small area of the back to remove hair using a dampened gauze pad and sterile water. Next, a detecting device that can measure fluorescent compounds transcutaneously in blood was fixed to the shaved area of the mouse. FITC-sinistrin was dissolved in saline solution and injected into the femoral vein at a dose of 15 mg/ 100 g body weight and monitored for 2 h after injection. Data was analyzed using MPD Studio software (Mannheim Pharma and Diagnostics, Amtsgericht Mannheim, Germany). GFR was calculated by obtaining the half-life of the FITC-sinistrin curve and using the rate constant value as described [38] .
Statistical analysis
All results are expressed as ± Standard Deviation. Comparison between the groups was done using one-way ANOVA followed by a least squared difference (LSD) post-hoc test using Prism 5.0 (Graph Software, San Diego, CA). Significance was achieved with a p-value of p < 0.05.
Results
Gut microbiota alterations
We employed 16S rRNA sequencing to samples extracted from stool from each of the four groups at the end of the treatment period to gain a perspective on genra abundance in each treatment group in each phyla. We did not observe a substantial shift in the relative abundance of Firmicutes or Bacteroidetes in the control (52.7%) and Ang-II (53.7%) treatment groups (Fig. 1A) . However, the abundance of Firmicutes was decreased in GYY only (48.5%) and Ang-II + GYY (45.7%) groups with an accompanying increase in Bacteroidetes adundance (Fig. 1A) . Examining more in depth, we did observe a substancial higher abundance in Erysipelotrichi of the Firmicutes phylum compared to the other three groups (Fig. 1B) .
Short chain fatty acid receptors are altered in hypertension kidney
To determine whether Ang-II induced hypertension affected the expression of SCFA receptors in the kidney, we performed qPCR analysis on three different SCFA receptors that have been shown to have a role in hypertension and immunity. Olfr78 expression, which was previously shown to promote vasoconstriction, was found to be upregulated in the hypertension kidney ( Fig. 2A) . Gpr41 and Gpr43 expression, on the other hand, were shown to be downregulated in the hypertensive kidney ( Fig. 2A) . GYY supplementation reduced the levels of Olfr78 as well as induced Gpr41 and Gpr 43 expression, bringing them closer to control levels ( Fig. 2A) . These results were supported by Western blot analysis with Ang-II treated animals having higher expression of Olfr78 and lower levels of Gpr41 and Gpr43 (Fig. 2B-C) . Protein levels of all three receptors were normalized in mice supplemented with GYY. We observed that Gpr41 was localized to tubules and vessels in the kidney while Gpr43 was more concentrated in the glomerulus (Fig. 2D) . We found Olfr78 to be expressed in the glomerulus as well, with minimal expression in all but hypertensive kidney (Fig. 2E) .
Ang-II promotes inflammation in the hypertensive kidney and is suppressed by GYY supplementation
Previous work has shown Ang-II promotes inflammation-induced kidney injury, in part, through Tgfβ pathway [7] . In addition, Retinoic acid-related orphan receptor gamma t (Rorγt) is a transcription factor important in T-cell development as well as promoting Il-17a productions, a cytokine implicated in hypertension [39, 40] . Gene expression analysis revealed inflammation-promoting targets Tgfβ, Il-6, and both isoforms of Rorγ (Rorc1γ/Rorc2γ) were upregulated in the hypertensive kidney (Fig. 3A) . Gpr120 expression, which is a long chain fatty acid receptor with reported anti-inflammatory effects [41] , was found to be downregulated in the hypertensive kidney (Fig. 3A) . GYY supplementation reduced levels of inflammatory markers as well as increased Gpr120 expression (Fig. 3A) . These results were also observed at the protein level (Fig. 3B-C) . Tgfβ and Il6 expression were found to be localized in the glomerulus whereas Rorc2γ was increased in the vessels and tubules (Fig. 3D-E) . Gpr120 expression followed a similar pattern to that of Rorc2γ and was elevated in GYY treated kidneys (Fig. 3F) .
miRNA regulation of short chain fatty acid receptors
In an effort to determine if miRNAs had a regulatory role for short chain fatty acid receptors in the kidney, we transfected mouse glomerular endothelial cells with miRNA mimics and inhibitors for miR-132 and miR-329. These miRNAs were previously found to have been altered in the hypertensive kidney [27] and in silico analysis of these miRNAs revealed potential targeting of SCFA receptors by these miRNAs, with miR-132 targeting Gpr43 and miR-329 and Gpr41. Mimics of all three miRNAs transfected into cells showed a moderate decrease in target protein expression (Fig. 4A-B) . Inhibitors and controls transfected into cells revealed no significant changes in target protein expression (Fig. 4B) .
Kidney function is improved with GYY supplementation
Glomerular filtration rate (GFR) remains an important measurement in determining kidney function. To determine if kidney function is reduced in Ang-II treated mice, we injected fluorescently-labeled sinistrin (FITC-sinistrin) into the femoral vein of anesthetized mice and attached a detector to transcuteaneously measure the efficiency of FITC-sinistrin being filtered by the kidney. We found the GFR to be significantly reduced in mice treated with Ang-II, but was normalized when supplemented with GYY (Fig. 5) . GYY treatment alone increased GFR, albeit not significantly (Fig. 5 ).
Intestinal integrity
Zonulin is an intestinal structural protein known to have a role in maintaining intestinal integrity by maintaining tight junction proteins as well as a noted promoter of inflammation [42] [43] [44] . Haptoglobin is a preproprotein which can be processed into zonulin and a potential marker for barrier integrity [45] . Using an ELISA, we found circulating plasma levels of haptoglobin were increased in hypertensive mice compared to controls (Fig. 6A ). Mice supplemented with GYY in either group had reduced levels of haptoglobin compared to Ang-II (Fig. 6A) . As this protein is a marker for intestinal barrier integrity, we tested whether contents from the gut were leaking into the bloodstream and being carried to other organ systems, i.e. the kidney. Primers targeting bacterial specific rRNA were used in a PCR reaction to determine if bacteria had leaked from the gut to the kidney. We found higher expression in Ang-II kidney samples compared to other groups, indicating bacteria may be leaking from the gut into the blood. 
Discussion
The role(s) of gut microbiota in regulating physiological processes and linking changes in microbiome composition to varies diseases and disorders have been received a great deal of attention and investigation in the past several years. Understanding how, why and, importantly, what affects gut microbiota may lend insight into therapeutic intervention of multiple diseases. One of the factors that influences gut microbiome composition is diet [46] . This change in composition will yield different amounts of normal byproducts and metabolites that are produced in the gut. One major category of metabolites produced in the gut are SCFAs, which are derived from dietary fibers digested mainly in the colon [47] . SCFAs can enter into the bloodstream and tissues through diffusion or through monocarboxylate transporters [48] . Three of the main studied SCFAs are butyrate, acetic and propionic acids. Once these SCFAs enter the bloodstream, they will bind to their respective receptors and elicit a physiological response. Some of these receptors have been shown to play a role in blood pressure regulation, including Olfr78 and Gpr41 [22, 23] . Both of these receptors reside in the kidney and when stimulated, have different effects on the tissue, with Olfr78 shown to have hypertensive effects and Gpr41 hypotensive. However, little is known about the regulation of the SCFA receptors in the kidney. In this study, we found Olfr78 increases in expression in the hypertensive kidney, which likely enhances vasoconstriction, leading to kidney injury and a sustained hypertensive state. Moreover, Gpr41, which is reported to have hypotensive effects, was decreased in the kidney of mice treated with Ang-II, further amplifying the effects of Ang-II on the kidney.
With respect to how these SCFA receptors might be regulated in the kidney, we identified several miRNAs miR-132, and miR-329, which have been previously found to be altered in the hypertensive kidney [27] that target and potentially bind to SCFA receptors reported in this study. In silico analysis predicted miR-329 would target Gpr41 and miR-132 would bind to Gpr43. We found through transfection experiments for miR-132 and miR-329 that overexpression via mimics led to a decrease in protein expression for each miRNA-gene target. It is interesting to note that our previous study found miR-329 and miR-132 to be upregulated in the hypertensive kidney whereas miR-129 was downregulated. miR-129 was predicted to target Olfr78, however, the expression of this receptor was low in this cell line and we were unable to get a signal to observe any change in expression. In addition, GYY supplementation normalized the levels of these miRNAs, further supporting regulatory roles of miRNAs in the kidney and specifically of SCFA receptors.
We, as well as others, have investigated the role inflammation has in hypertension and the damage it causes to the kidney. Tgfβ has been shown to be responsive to Ang-II treatment and has been linked with renal fibrosis in hypertension [49] . A recent study showed that Tgfβ and Il6 were both upregulated in the hypertensive kidney through Tolllike receptor 4 (TLR4) immune response pathway [7] . Here, we recapitulate the upregulation of both these molecules in the kidney of Ang-II treated wild-type mice. Moreover, supplementation with GYY reduces expression of both these inflammatory mediators. In addition, we also explored a role for Rorc2 (Rorcγt), which is involved in the maturation and regulation of Th17 cells [40, 50] . This process appears to occur in CD4+ lymphocytes and promotes Il-17 production, a prominent cytokine in hypertension [39, 51] . Here, we assessed both isoforms of Rorc, which were found to be upregulated the kidney of Ang-II treated animals. We followed up with protein and immunofluorescence assays for Rorc2, as this isoform is believed to be responsible for Il-17 regulation, and found this protein localized to the tubules and vessels of the kidney. While Rorc2 regulates Il-17 in lymphocytes, the role of this transcription factor in kidney is still unknown. GYY supplementation normalized the expression of Rorc2, supporting the role of hydrogen sulfide as an anti-inflammatory agent. As we were interested in SCFA receptors, we also investigated the long chain fatty acid receptor Gpr120. This receptor binds omega-3 fatty acids and may act as an antiinflammatory receptor by suppressing macrophage-mediated inflammation [41] . Here, we investigated a role of Gpr120 in the kidney and found that this receptor is downregulated in hypertension but induced with GYY supplementation. While the mechanism of action is not known, our results suggest this receptor has a role in the kidney during hypertension, possibly as an anti-inflammatory mediator. Alteration of the gut microbiome has been implicated in a number of diseases, including hypertension [52] [53] [54] . Two of the major phyla composing the gut microbiome are Bacteroidetes and Firmicutes, with a shift in the ratio of these bacteria associated with hypertension [55] . While we did not observe this increase in F/B ratio in hypertensive mice, we did find GYY supplementation substantially reduced the overall abundance of Firmicutes while increasing Bacteroidetes. Moreover, we found the highest abundance of Erysipelotrichi, which is a class of bacteria in the Firmicutes phylum and has been linked with high fat diet and obesity [56] . The context in which this enrichment has in hypertension remains to be studied and it is worth speculating that the smaller classes and bacteria may influence the microbiome in critical ways that are not necessarily reflected at the phyla level. It is also known that hypertension can cause intestinal barrier damage and result in leakage of the gut contents into the bloodstream. Zonulin is one marker that has been associated with loss of barrier integrity along with its precursor haptoglobin [42, 45] . We observed a significant increase in Fig. 3 . Ang-II induced inflammatory response in kidney. (A) Inflammatory markers were assessed by qPCR, including Tgfβ, Il6, Rorc1γ, Rorc2γ, and reported antiinflammatory fatty acid receptor Gpr120. (B) Western blot analysis and (C) bar graph of protein levels inflammatory markers and long chain fatty acid receptor Gpr120. Bar graphs are the mean intensities ± SD. n = 5/group. *p < 0.05 Control vs. Ang-II; (D) Immunostaining for Tgfβ and Il6 showed increased expression and localization in glomeruli (white arrows). (E) Immunostaining for Rorcγ showed increased expression and localization in the tubules and vessels around the glomerulus while (F) Gpr120 was less in hypertensive kidney (white arrows). GYY increased expression of Gpr120. Magnification, ×60. Scale bars, 40 μm.
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Pharmacological Research 134 (2018) [157] [158] [159] [160] [161] [162] [163] [164] [165] haptoglobin protein in plasma of mice treated with Ang-II compared to other groups, suggesting the gut barrier was damaged as zonulin is structural tight junction protein. Supporting this result was the presence of bacteria in the kidney as detected by PCR in hypertensive mice whereas GYY supplemented animals did not appear to have a bacterial presence in the kidney. The presence of localized bacteria in the kidney may account for part of the inflammatory response markers observed as well. In summary, we have provided evidence for miRNA regulation of SCFA receptors in the kidney causing an enhanced hypertensive response along with bacterial leakage from the gut from a compromised intestinal barrier lead to a localized inflammatory response and further causing kidney damage. Small changes in the gut microbiome may also affect the intestinal barrier and promote leakage, thereby amplifying the overall hypertensive affect. Fig. 7 is a proposed model of these events whereby hypertension can cause gut dysbiosis, damage the intestinal barrier, allow bacteria to leak out and attach to other organs, such as the kidney, and cause inflammation-induced damage. Further, SCFA can stimulate vasoconstriction through increased Olfr78 expression, causing further damage and perpetuating the cycle, which can be alleviated through hydrogen sulfide supplementation.
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This study was supported in part by U.S. National Institutes of Health (NIH) GrantsDK104653 (U.S.) and American Heart Association Scientist Development Grant15SDG25840013 (S.P.). Fig. 4 . miRNAs target SCFA receptors in vitro. Mouse Glomerular Endothelial Cells were transfected with mimics, inhibitors, and controls, against miR-132 and miR-329. In silico analysis using target software predicted miR-132 would target Gpr43 and miR-329 binding to Gpr41. (A) One hundred μg of protein was resolved on SDS-PAGE gels and probed with appropriate antibodies overnight. Band intensities were quantified using ImageJ. (B) Bar graphs are the mean intensities ± SD. n = 4/ group. *p < 0.05. Fig. 5 . Glomeruluar filtration rate is improved in mice supplemented with GYY. Live, conscious mice were anesthetized with isoflurane and injected with FITCsinistrin (15 mg/100 g) into the femoral artery. Detector was fixed to area removed of hair and mice were put back into cages while the detector took measurements for 2 h. GFR was calculated after obtaining half-life of excreted FITC-sinistrin. Bar graph, n = 5/group. *p < 0.05. Fig. 6 . Intestinal barrier integrity is compromised in hypertensive mice. (A) Plasma samples were diluted 1/10,000 and added to ELISA sandwich with antibody to haptoglobin. The plate was washed and then exposed to substrate to reveal expression. Absorbance was detected at 480 nm wavelength. Bar graph, n = 5/group. *p < 0.05 (B) gDNA extracted from kidney was purified and set up for a PCR reaction, using 100 ng sample and primers specific to bacteria. At the end of the PCR run, samples were loaded onto a 1% agarose gel and imaged. 
